Skip to main content

Types of COVID-19 vaccines in development

 


Known safety profile: inactivated vaccines better known than protein subunit and nucleic acid and these two are better than viral vector

Whole virus vaccines use a weakened (attenuated) or deactivated form of the pathogen that causes a disease to trigger protective immunity to it.  There are two types of whole virus vaccines. 

1. Live attenuated vaccines use a weakened form of the virus, which can still grow and replicate, but does not cause illness.

2. Inactivated vaccines contain viruses whose genetic material has been destroyed by heat, chemicals or radiation so they cannot infect cells and replicate, but can still trigger an immune response.

Both are known, tried and tested vaccination strategies, which form the basis of many existing vaccines – including those for yellow fever and measles, shingles (live attenuated vaccines), or seasonal influenza and hepatitis A (inactivated vaccines). 


ADVANTAGES AND DISADVANTAGES OF LIVE ATTENUATED VACCINES

Well-established technology

Strong immune response

Immune response involves B cells and T cells

Relatively simple to manufacture

Unsuitable for people with compromised immune systems

May trigger disease in very rare cases

Relatively temperature sensitive, so careful storage necessary


ADVANTAGES AND DISADVANTAGES OF INACTIVATED VIRUS VACCINES

Well-established technology

Suitable for people with compromised immune systems

No live components, so no risk of the vaccine triggering disease

Relatively simple to manufacture

Relatively stable

Booster shots may be required


Inactivated vaccines:

Three from China (Sinovac, China, Brazil, UAE, few other countries)

One from India (Covaxin, INDIA)

One from Khazakhstan










https://www.gavi.org/vaccineswork/what-are-whole-virus-vaccines-and-how-could-they-be-used-against-covid-19

Comments

Post a Comment

Popular posts from this blog

Mounjaro, Is it a game changer for weight loss and diabetes?

  MOUNJARO™ ( Tirzepatide) was approved for medical use in the United States in May 2022 WEIGHT LOSS: (Not approved by FDA for weight loss) Eli Lilly and Company is  finalizing an application to the U.S. Food and Drug Administration for fast-track approval to sell tirzepatide for chronic weight management. MOUNJARO™ is a glucose-dependent insulinotropic polypeptide (GIP) receptor and glucagon-like peptide-1 (GLP-1) receptor agonist indicated in adults for type 2 diabetes mellitus management. CONTRAINDICATIONS Personal or family history of medullary thyroid carcinoma or in patients with Multiple Endocrine Neoplasia syndrome type 2  Known serious all to tirzepatide or any of the excipients in MOUNJARO                                                                    ...
Post a Comment
Read more

Respiratory syncytial virus (RSV) ---cough

Respiratory syncytial virus (RSV) is a leading cause of severe lower respiratory tract disease in young children. Recent RSV strain in Utah is  causing moderate to severe cough (especially during night), weakness and cold-like symptoms .  RSV infection is sometimes severe and is associated with hospitalization, mechanical ventilation, long-term complications, decreased quality of life, loss of work productivity and patient/caregiver stress.  RSV may cause inflammation and infection of small airways and lungs.  Recovery time usually ranges from 7 to 14 days, but RSV can cause serious disease. RSV combined with increasing flu circulation are keeping some hospitals and pharmacies occupied.  Seventeen states are reporting that more than 80% of beds are full, according to the data. Children’s hospitals in Utah, Arizona, the District of Columbia, Maine, Minnesota, Rhode Island, and Kentucky are almost completely at capacity. RSV can spread when viral droplets from a ...
Post a Comment
Read more

Sodium chloride Tablets USP

A 91- year old patient. Admitted to the hospital from the ED. Patient was seen for altered mental status. Labs, CT of brain head, CXR XR of left Tib/Fib were performed. Presumed meningioma in the left middle cranial fossa was noted. Sodium was critically low at 114. Nephrologist was consulted and hyponatremia is of unknown etiology. Patient also has uncontroled hypertension. Comorbidities: Coronary artery disease, Diabetes, Dementia, hypothyroidism, hyperlipedemia, neuropathy. Patient will need physicain oversight for hyponatremia, normal saline routinely, and medication management for hypertension. Rx: Sodium Chloride USP 1.0 gram Use  1. Hyponatremia 2. Preparation of normal isotonic solution of sodium chloride 3. As an electrolyte replenisher for the prevention of heat cramps, due to excessive  perspiration 4. any alternate use as directed by a physician Each tablet contains: sodium 394mg Hyponatremia  is a common electrolyte disorder encountered i...
7 comments
Read more